Cargando…
Primary Percutaneous Coronary Intervention with High-Bolus Dose Tirofiban: The FASTER (Favorite Approach to Safe and Effective Treatment for Early Reperfusion) Multicenter Registry
OBJECTIVES: To investigate the safety and clinical efficacy of tirofiban during primary percutaneous coronary interventions (pPCI). BACKGROUND: Gp IIb/IIIa inhibitors (GPI) use during pPCI has declined over years, mainly for the increased hemorrhagic risk associated to their use and for the availabi...
Autores principales: | Rigattieri, Stefano, Lettieri, Corrado, Tiberti, Gianluca, Romano, Michele, Ferlini, Marco, Testa, Luca, Pierini, Simona, Ettori, Federica, Passamonti, Enrico, Marchese, Alfredo, Musumeci, Giuseppe, Esposito, Giovanni, Tarantini, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983258/ https://www.ncbi.nlm.nih.gov/pubmed/35418809 http://dx.doi.org/10.1155/2022/9609970 |
Ejemplares similares
-
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial
por: Gargiulo, Giuseppe, et al.
Publicado: (2020) -
High Bolus Tirofiban vs Abciximab in Acute STEMI Patients Undergoing Primary PCI – The Tamip Study
por: Balghith, Mohammed A.
Publicado: (2012) -
Microcatheter infusion of bolus-dose tirofiban for acute ischemic stroke due to distal intracranial artery occlusion
por: Shao, Shao Ju, et al.
Publicado: (2020) -
Russian favorites
Publicado: (1996) -
Favorite Prescriptions
Publicado: (1890)